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Abstract
In humans, chronic ethanol consumption leads to a characteristic set of changes to the metabolism
of lipids in the liver that is referred to as an "alcoholic fatty liver (AFL)". In severe cases, these
metabolic changes result in the enlargement and fibrillization of the liver and are considered risk
factors for cirrhosis and liver cancer. Clock-mutant mice have been shown to display abnormal lipid
metabolism and alcohol preferences. To further understand the potential interactions between
ethanol consumption, lipid metabolism, and the circadian clock, we investigated the effect of
chronic ethanol intake on the lipid metabolism of Clock-mutant mice. We found that ethanol
treatment produced a number of changes in the liver of Clock-mutant mice without impacting the
wild-type controls. First, we found that 8 weeks of exposure to ethanol in the drinking water
increased the weight of the liver in Clock-mutant mice. Ethanol treatment also increased triglyceride
content of liver in Clock-mutant and wild-type mice. This increase was larger in the mutant mice.
Finally, ethanol treatment altered the expression of a number of genes related to lipid metabolism
in the Clock-mutant mice. Interestingly, this treatment did not impact circadian clock gene
expression in the liver of either genotype. Thus, ethanol produces a number of changes in the liver
of Clock-mutant mice that are not seen in the wild-type mice. These changes are consistent with
the possibility that disturbance of circadian rhythmicity associated with the Clock mutation could
be a risk factor for the development of an alcoholic fatty liver.
Background
In humans, chronic ethanol consumption leads to a char-
acteristic set of changes to the metabolism of lipids in the
liver that is referred to as an "alcoholic fatty liver" (AFL)
[1]. This condition is characterized by an increase in liver
weight [2], the accumulation of triglycerides and changes
in expression of genes involved in lipid metabolism [3].
In severe cases, these changes eventually lead to inflam-
mation [4] and steatohepatitis [5] and are considered risk
factors for cirrhosis and liver cancer in humans. Most of
these changes are also observed in rodents [6] allowing us
to use chronic alcohol exposure in rodents as a model to
understand the human condition.
In recent years, many of the genes responsible for the gen-
eration of circadian rhythms have been identified [7].
Many of these genes have been found to be expressed in
the liver where the transcription of a number of key genes
is regulated on a circadian time scale [8]. Mice containing
a mutation in the transcription factor, CLOCK, are unable
to generate circadian rhythms in behavior and hepatic
gene expression [9,10]. Interestingly, recent studies sug-
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gest that Clock-mutant mice exhibit abnormal triglycerides
[11], cholesterol metabolism [12], and become obese
[13]. Therefore, to understand the potential interactions
between ethanol consumption, lipid metabolism and the
circadian clock, we investigated the effect of chronic etha-
nol intake on the lipid metabolism of Clock-mutant mice.
Methods
Animals
Clock-mutant mice were purchased from The Jackson Lab-
oratory (stock no. 002923, Bar Harbor, ME). These mice,
originally with the Clock  allele on a C57BL/6J back-
ground, were backcrossed using a Jcl: ICR background
more than eight generations. We placed them in the ICR
genetic background to enhance the robustness of the
breeding and care of the young. Other groups have
reported that the Clock-mutant mice with a C57BL/6J
background died in their infancy because the dams did
not care for them [14-16]. Clock-mutant mice were heter-
ozygous, and genotypes were determined using PCR. We
used eight- to ten-week-old female wild-type and Clock-
mutant mice that were isogenic siblings born in the same
litters. Female mice were used because females are more
vulnerable than males to the effects of alcohol [17]. Mice
were maintained on a light-dark (LD) cycle (12 hours
light, 12 hours dark with lights on at 8:00 a.m., room tem-
perature of 23 ± 1°C) and provided with a standard diet
(Oriental Yeast Co., Ltd., Tokyo, Japan) and water ad libi-
tum. During the ethanol treatment, wild-type and Clock-
mutant mice were given water or 15% ethanol for 8 weeks
(n = 16 per group), and then mice were sacrificed at ZT 0,
6, 12, or 18. Zeitgeber time (ZT) 0 and 12 were the lights-
on and lights-off times, respectively. Animal care and
experiments were conducted under the permission of the
'Experimental Animal Welfare Committee in the School
of Science and Engineering at Waseda University' (permis-
sion number: 05G19).
Assay for serum triglyceride, cholesterol, free fatty acid, 
alanine aminotransferase, aspartate aminotransferase, 
and ethanol content
Blood samples (500 to 750 μl) from each mouse were col-
lected from the orbital sinus and centrifuged. A sample
(20 μl) of the serum from each mouse was used to obtain
triglyceride content with the Triglyceride E-test Wako
(Wako Pure Chemical Industries, Osaka, Japan), choles-
terol content with the cholesterol E-test Wako (Wako Pure
Chemical Industries, Osaka, Japan), free fatty acid content
with the NEFA C-test Wako (Wako Pure Chemical Indus-
tries, Osaka, Japan), alanine aminotransferase, aspartate
aminotransferase content with the Transaminase CII-test
Wako (Wako Pure Chemical Industries, Osaka, Japan),
and ethanol content with the F-kit Ethanol UV-test UV
method (r-biophram, Darmstadt, Germany). These were
done according to the instructive manual.
Assay for liver triglyceride content
An assay for liver triglyceride content was performed
based on methods described by Yokode et al. [18]. From
each mouse, 0.2 g of liver tissue was homogenized in a
Polytron homogenizer with 4 ml chloroform/methanol
(2/1, v/v), after which 0.8 ml of 50 mM NaCl was added.
A sample (50 μl) of the organic phase was mixed with 7.5
mg of Triton X-100. After evaporation of the organic sol-
vents, the lipid in the detergent phase was used to measure
TG content with the Triglyceride E-test Wako (Wako Pure
Chemical Industries, Osaka, Japan).
Oil red O stain of the liver
In order to elucidate whether or not ethanol led to higher
lipid accumulation in the liver of Clock-mutant mice com-
pared to wild-type mice, we examined the accumulation
of lipids using the oil red O stain method [11]. Mouse liv-
ers were fixed with 10% formalin and sliced in 10 μm sec-
tions with a cryostat (LEICA, Wetzlar, Germany). Next, the
livers were washed in PBS solution for 30 sec, 60% isopro-
pyl alcohol for 1 min, and stained by oil red O for 10 min
at 37°C. Thereafter, slices were fractionated with 60% iso-
propyl alcohol for 2 min, washed with PBS solution for 2
min, and stained with hematoxylin for 5 min. After the 2
min wash in PBS solution, slices were colored with lith-
ium carbonate for 30 sec, washed with PBS solution for 5
min, and cover slipped.
RNA isolation and Real time RT-PCR
Total RNA was extracted using ISOGEN Reagent (Nippon
Gene, Tokyo, Japan). Fifty nanograms of total RNA was
reverse transcribed and amplified using the One-Step
SYBR RT-PCR Kit (TaKaRa, Otsu, Japan) in the iCycler
(BIO RAD, Hercules, CA). Specific primer pairs were
designed based on the following published data on the
Acc1, β-actin, Dbp, Mtp, and Per2 genes in GenBank (Table
1). RT-PCR was executed under the following conditions:
cDNA synthesis at 42°C for 15 min followed by 95°C for
2 min, PCR amplification for 40 cycles with denaturation
at 95°C for 5 sec, and annealing and extension at 60°C for
20 sec. The relative light unit of the target gene PCR prod-
ucts was normalized to that of β-actin. A melt curve anal-
ysis was then performed.
Statistical Analysis
The values are expressed as means ± standard error of the
mean. For statistical analysis, one-way or two-way
ANOVA were applied and post hoc analysis was con-
ducted in the Fisher PLSD test.
Results
Chronic ethanol increased liver weight in Clock-mutant 
mice
Chronic alcohol consumption leads to hypertrophy of the
liver in humans [2] and rats [19]. Therefore, we sought toJournal of Circadian Rhythms 2009, 7:4 http://www.jcircadianrhythms.com/content/7/1/4
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determine the impact of exposure to ethanol (8 weeks) on
the mouse liver. We found that this ethanol treatment sig-
nificantly increased the liver weight of the Clock-mutant
mice (Fisher PLSD, F(3, 60) = 3.894, P < 0.05, Fig. 1)
while wild-type mice did not exhibit a change in liver
weight. There were no differences between wild-type mice
and Clock-mutant mice in the ethanol intake or in serum
levels of ethanol (Table 2). Similarly, there were no differ-
ences in food intake and body weight between the two
genotypes (Table 2). Finally, alanine aminotransferase
(ALT) and aspartate aminotransferase (AST) are impor-
tant enzymes produced by the liver and serum levels of
these enzymes are widely used biomarkers of liver health
[20]. We found that ethanol treatment did not alter levels
of AST or ALT in either genotype (Table 2). These results
demonstrate that the livers of Clock-mutant mice exhibit a
weight increase under conditions of ethanol exposure that
do not impact wild-type mice.
Chronic ethanol increased liver triglyceride content in 
Clock-mutant mice
Alcohol consumption can cause an increase in liver trig-
lyceride content in humans [3] and rats [21]. Therefore,
we also measured the impact of ethanol exposure on
mouse liver triglyceride levels. We found that ethanol
intake increased triglyceride content in the liver of both
genotypes (Fisher PLSD, F(3, 60) = 18.0, P < 0.01, Fig.
2A). Moreover, the ethanol-induced increase in liver trig-
lyceride content was significantly higher in Clock-mutant
mice compared with wild-type (Fisher PLSD, F(3, 60) =
18.0, P < 0.01). We measured liver triglyceride throughout
the daily cycle (ZT 0, 6, 12, and 18) and found that the
ethanol treatment increased triglyceride levels regardless
Table 1: Sequences of primer pairs used to amplify each PCR product
Gene Sequence Predicted Size (bp) GenBank Accession No.
Acc1
Sense 5'-GCACTCCCGATTCATAATTG-3' 141 NM_133360 (34–185)
Antisense 5'-CCCAAATCAGAAAGTGTATC-3'
Aco
Sense 5'-ATCTATGACCAGGTTCAGTCGGGG-3' 237 NM_015729 (1312–1548)
Antisense 5'-CCACGCCACTTCCTTGCTCTTC-3'
β-actin
Sense 5'-TGACAGGATGCAGAAGGAGA-3' 131 AK075973 (1009–1139)
Antisense 5'-GCTGGAAGGTGGACAGTGAG-3'
Dbp
Sense 5'-CCGTGGAGGTGCTAATGACCT-3' 105 NM_016974 (984–1087)
Antisense 5'-CCTCTGAGAAGCGGTGTCT-3'
Mtp
Sense 5'-GCCCTAGTCAGGAAGCTGTG-3' 127 NM_008642 (1300–1426)
Antisense 5'-CCAGCAGGTACATTGTGGTG-3'
Per2
Sense 5'-TGTGTGCTTACACGGGTGTCCTA-3' 142 AF036893 (5563–5704)
Antisense 5'-ACGTTTGGTTTGCGCATGAA-3'
Ppar α
Sense 5'-TCTTCACGATGCTGTCCTCCT-3' 142 NM_011144 (1395–1475)
Antisense 5'-GGAACTCGCGTGTGATAAAGC-3'
Chronic ethanol exposure increases liver weight in Clock- mutant mice Figure 1
Chronic ethanol exposure increases liver weight in 
Clock-mutant mice. Eight- to ten-week-old wild-type 
(WT, n = 16) and Clock-mutant (Ck, n = 16) mice were given 
15% ethanol in drinking water for 8 weeks. At the end of this 
treatment, liver and body weights were measured. Clock-
mutant mice exhibited a significant (ANOVA, Fisher PLSD, P 
< 0.05) increase in liver/body weight (A) as well as % change 
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of the time of day (Fig. 2B and 2C). Histological analysis
indicated that the liver tissue from the ethanol treated
mice exhibited greater staining by oil red O. While quali-
tative, this increase in staining is consistent with lipid
accumulation in ethanol treated mice (Fig. 3). In contrast
to the data from the liver, we found that ethanol exposure
did not alter measured levels of triglyceride or cholesterol
in the serum of mice from either genotype (Table 2). This
data indicates that ethanol treatment increases levels of
triglyceride in the mouse liver and that this lipid accumu-
lation is greater in Clock-mutant mice than in wild-type
mice.
Chronic ethanol altered the expression of genes involved in 
lipid metabolism in Clock-mutant mice
In order to investigate the possible mechanisms underly-
ing these effects of ethanol on the lipid content, we inves-
tigated the impact of ethanol treatment on 4 genes that are
critically involved in lipid metabolism (Fig. 4). First, we
found that ethanol treatment significantly increased the
expression of Acc1  in the liver of Clock-mutant (Fisher
PLSD, F(3, 60) = 13.069, P < 0.01) but not wild-type mice.
Second, we found that ethanol treatment decreased the
expression of Aco (F(3, 60) = 6.27, P < 0.05) in Clock-
Table 2: Impact of ethanol exposure on wild-type and Clock-mutant mice
Wild-type Clock-mutant
Control Ethanol Control Ethanol
Ethanol Intake (g/kg/day) na 30.5 ± 2.0 na 27.2 ± 1.6
Food Intake (g/kg/day) 154 ± 11 136 ± 13 154 ± 14 136 ± 10
Body Weight (g) 32.3 ± 0.6 32.3 ± 0.6 33.0 ± 0.5 31.9 ± 0.5
Serum Ethanol (mM) na 9.0 ± 2.3 na 9.4 ± 1.8
Serum TG (mg/dl) 68 ± 6.4 84 ± 8.5 62 ± 4.8 71 ± 4.9
Serum CH (mg/dl) 64.2 ± 4.7 60.2 ± 4.8 64.5 ± 3.0 62.2 ± 2.9
Serum FFA (mEq/l) 0.50 ± 0.03 0.53 ± 0.03 0.52 ± 0.03 0.46 ± 0.02
Serum ALT (Karmen) 28.0 ± 0.7 26.1 ± 0.5 30.1 ± 1.3 27.2 ± 0.3
Serum AST (Karmen) 75.0 ± 6.5 61.8 ± 2.9 62.8 ± 4.2 59.6 ± 2.3
TG, triglycerides; CH, cholesterol; FFA, free fatty acids; ALT, alanine aminotransferase; AST, aspartate aminotransferase, na; not available
Chronic ethanol increases liver triglycerides (TG) content in  Clock-mutant mice Figure 2
Chronic ethanol increases liver triglycerides (TG) 
content in Clock-mutant mice. (A) Ethanol exposure sig-
nificantly increased the TG levels in both WT (n = 16) and 
Ck (n = 16) mice. Further analysis by two-way ANOVA indi-
cates that the ethanol-induced increase was greater in the 
mutant mice (P < 0.01). (B) In WT mice, ethanol exposure 
significantly increased liver TG at ZT 0, 6, and 18 (n = 4 for 
each time point). (C) In Ck mice, ethanol exposure signifi-
cantly increased liver TG at ZT 12 and 18 (n = 4 for each 
time point). Values are means ± SEM. Significance was initially 
determined using the one-way ANOVA followed by Fischer 





































































































Chronic ethanol increases liver lipid content in Clock-mutant  mice Figure 3
Chronic ethanol increases liver lipid content in Clock-
mutant mice. The intensity of staining of liver tissue with 
oil red O provides a qualitative measure of the lipid content. 
We found that ethanol exposure increases the intensity of 
the oil red O staining. Representative oil red O staining of 
liver tissue in WT and Ck mice on control and ethanol (A-
D). Images from the stained liver were magnified ×400 and 
scale bar is shown.Journal of Circadian Rhythms 2009, 7:4 http://www.jcircadianrhythms.com/content/7/1/4
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mutant but not wild-type mice. Third, we found that both
Clock-mutant and wild-type mice exhibited an ethanol-
induced reduction in Mtp expression (Fisher PLSD, F(3,
60) = 7.601, Clock-mutant: P < 0.05; wild-type: P < 0.05).
Finally, we found that ethanol treatment tended to
decrease the expression of Pparα in Clock-mutant but this
effect was not significant. These data demonstrate that
ethanol-treatment can alter the expression of genes
involved in lipid metabolism in the mouse liver and that
Clock-mutant mice exhibit different ethanol-induced
change than wild-type mice.
Chronic ethanol does not alter the expression of circadian 
clock genes
Finally, we examined the impact of ethanol on the expres-
sion of circadian clock genes in the mouse liver. In wild-
type mice, the expression of both Per2 and Dbp showed a
clear daily rhythm with peaks at ZT 12. In Clock-mutant
mice, the amplitude was damped (Per2, control: from 7.7
to 3.5, ethanol: 8.0 to 5.5, Dbp, control from 26 to 11, eth-
anol from 23 to 16) but still exhibited peak expression at
ZT 12. Exposure to ethanol did not significantly affect the
average level of Per2 and Dbp gene expression in either
genotype (Fig. 5). Therefore, our data suggests that etha-
nol exposure does not alter the expression of circadian
clock genes in the liver.
Discussion
The liver plays a key role in the metabolism of alcohol and
is also sensitive to the deleterious effects of chronic alco-
hol consumption. In humans, chronic alcohol consump-
tion leads to a characteristic set of changes to the
metabolism of lipids in the liver that is referred to as an
"alcoholic fatty liver". In humans, AFL is characterized by
an increase in liver weight, accumulation of triglyceride
and changes in the expression of genes involved in lipid
metabolism. In severe cases, these metabolic changes
Chronic ethanol alters the expression of genes involved in  lipid metabolism in Clock-mutant mice Figure 4
Chronic ethanol alters the expression of genes 
involved in lipid metabolism in Clock-mutant mice. 
We investigated the impact of ethanol treatment on 4 genes 
that are critically involved in lipid metabolism. Expression of 
Acc1 (A), Aco (B), Mtp (C), and Pparα (D) were measured 
from the liver (n = 16) with RT-PCR and product normalized 
to that of β-actin. Significance was determined using the one-















































































Chronic ethanol does not alter the expression of circadian  clock genes Figure 5
Chronic ethanol does not alter the expression of cir-
cadian clock genes. After exposure to ethanol, mouse liv-
ers were collected every 6 hours (n = 4 per time point). 
Expression of Per2 (A, B) and Dbp (C, D) was measured from 
the liver with RT-PCR and product normalized to that of β-
actin. Values are means ± SEM and normalized as average lev-
els of water-received wild-type mice become 1. Significance 
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result in the enlargement and fibrillization of the liver and
are considered risk factors for cirrhosis and liver cancer.
Previous work suggests that there may be links between
mutations in the circadian system and liver metabolism.
The transcription of many genes in liver, including those
involved in lipid metabolism, is regulated on the circa-
dian time scale [8,22]. Furthermore, mice with mutations
in core elements of the circadian timing system also
exhibit deficits in liver function. In the best studied exam-
ple, the Clock-mutant mice [9,23] exhibit abnormal trig-
lyceride [11], abnormal cholesterol metabolism [12], and
become obese over time [13]. In humans, common
genetic variations in CLOCK transcription factor are asso-
ciated with fatty liver disease [24]. To further understand
the potential interactions between ethanol consumption,
lipid metabolism, and the circadian clock, we investigated
the effect of chronic ethanol intake on the lipid metabo-
lism of Clock-mutant mice. We used a previously estab-
lished protocol in which mice are given drinking water
with 15% ethanol over the course of 8 weeks [25].
We found that ethanol exposure increased the weight of
the liver in Clock-mutant, but not wild-type mice (Fig. 1).
Previous studies have found that alcohol consumption
leads to increase in weight of liver of humans [2] and rats
[19]. This difference in liver weight between the two gen-
otypes could not be obviously explained by consumption.
The body weight between the two genotypes was not dif-
ferent with or without ethanol exposure (Table 2). Finally,
we saw little evidence for liver damage in the mice
exposed to this treatment regime. ALT and AST are impor-
tant enzymes produced by the liver and serum levels of
these enzymes are widely used biomarkers of liver health
[20]. Alcohol consumption leads to increase in ALT and
AST of humans [26] and rats [27], but not in wild-type or
Clock-mutant mice in the present study (Table 2). Thus,
the 8-week exposure to ethanol caused a modest and
selective increase in the weight of the liver of Clock-mutant
mice without causing overt liver damage. The mecha-
nisms underlying toxicity of ethanol associated with clock
gene expression should be discussed from the view point
of pharmacokinetics as well as pharmacodynamics. The
circadian rhythm of alcohol dehydrogenase activity was
previously reported in the rat liver [28]. Therefore, alcohol
metabolism might be disturbed in Clock-mutant mice,
and resulted in increase of blood ethanol level. However,
ethanol intake, and importantly, serum levels of ethanol
were not different between the wild-type and Clock-
mutant mice (Table 2). The hypothermic, hypnotic, and
also lethal effect of ethanol showed circadian variations
[29], suggesting that there is circadian rhythm in pharma-
codynamics of ethanol. Taken all evidences together, it is
suggested that we should consider the ethanol toxic effect
in the circadian rhythms of the pharmacokinetics and
pharmacodynamics, although mice did not show any evi-
dence for a daily rhythm in the levels of liver triglyceride.
Triglyceride is one of the most important lipids in the liver
and triglyceride in liver and serum are widely used meas-
ures of lipid metabolism [30]. Ethanol treatment also
increased triglyceride content of liver in Clock-mutant
mice as well as wild-type controls (Fig. 2). The ethanol-
induced increase in triglycerides was larger in the mutants
than in the wild-type mice. Previous studies in humans
[31] and rats [32] have also reported that ethanol
increases levels of triglyceride. There were the circadian
rhythm in Aco and Pparα, but not in Acc1 and Mtp. Analy-
sis of oil red O staining provides a qualitative measure of
the lipid content in the liver as higher levels of lipids leads
to stronger staining [11]. We found again that the ethanol-
treated group exhibited stronger staining than untreated
and that this increase in staining was more robust in the
Clock-mutant mice (Fig. 3). Therefore, both the triglycer-
ide measurements and the histological analysis suggest
that ethanol increases the lipid content in the liver and
that this effect is more robust in the Clock-mutant mice.
CLOCK is a transcription factor and Clock-mutant mice
exhibit a number of changes in the transcription of gene
in the liver [33]. The ethanol-induced increase in lipid
content of the liver of Clock-mutant mice could be
explained by changes in triglyceride synthesis, degrada-
tion, or transport from the liver to blood. Therefore, we
used RT-PCR methods to measure the expression of some
of the genes involved in triglyceride synthesis, degrada-
tion, or transport (Fig. 4). Triglyceride is synthesized by
fatty acids and glycerol released by the glycolytic pathway
[34]. In triglyceride synthesis, ACC1 [1] is the rate limiting
enzyme of Acyl-CoA synthesis from fatty acid in mouse.
We found that the Clock-mutant mice had higher baseline
levels of Acc1  and that ethanol-exposure produced a
strong increase in the expression of this gene. Another
important player in this pathway is Aco, which is involved
in triglyceride degradation by peroxisome β-oxidation
[35]. In the present experiment, gene expression of Aco in
the liver of Clock-mutant mice was significantly reduced
by ethanol intake. Thus, a reduction of β-oxidation by the
Clock mutation could also contribute to the high liver trig-
lyceride content. Finally, Mtp is a gene involved in the trig-
lyceride transport from the liver to blood [36]. Ethanol-
exposure decreases expression of Mtp in the liver of Clock-
mutant mice. A reduction of triglyceride export from the
liver through reduced Mtp expression may also explain the
increase of triglyceride content in the liver of Clock-mutant
mice. This gene expression data suggests that exposure of
Clock-mutant mice to ethanol produces a coordinated set
of changes in the expression of genes involved in triglyc-
eride synthesis, degradation and transport.Journal of Circadian Rhythms 2009, 7:4 http://www.jcircadianrhythms.com/content/7/1/4
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We also found that the expression of Pparα, which is
clock-controlled gene, was reduced by ethanol intake in
the Clock-mutant, but not in wild-type mice. It has been
reported that Pparα knock-out mice receiving ethanol for
eight weeks developed severe fatty liver [37]. Therefore,
the ethanol-induced decrease in Pparα expression could
be responsible for the abnormal lipid accumulations in
the liver of Clock-mutant mice. Interestingly, both Aco and
Mtp genes have PPRE sequences in their promoter regions
and receive a transcriptional regulation by Pparα [38,39].
Thus, ethanol-induced reduction in Pparα could explain
the reduction in the transcription of Aco, and Mtp. The
findings that the expression of these genes were reduced
in untreated Clock-mutant mice in comparison with wild-
type mice suggests that CLOCK is important for maintain-
ing higher expression levels of these metabolic genes. In
other words, these metabolic genes are controlled by Clock
genes through PPARα. The Clock knock-out mouse has no
central circadian phenotype [40], but Clock gene seems to
be indispensible for the functioning of peripheral tissue
clocks [41]. CLOCK protein has also been shown to be a
histon acetyl-transferase and this gene-regulatory func-
tion[42], which is not necessarily only acting on other
clock genes like Bmal1, may have to do with the liver phe-
notype shown here.
Thus, the ethanol-induced enlargement of the liver and
the increase of liver triglyceride in Clock-mutant mice
could be an early marker for alcohol-induced liver failure.
By itself, the Clock-mutation did produce some modest
changes in the levels of some of the genes involved in lipid
metabolism. These transcriptional changes did not appear
to result in any altered liver function at least with the
parameters that we could measure. On the other hand,
when we challenged the mutant mice with chronic expo-
sure to ethanol, we found the mutant mice exhibited an
increase in liver weight and lipid content. These mutant
mice also exhibited ethanol-induced changes in expres-
sion of genes involved in triglyceride synthesis and degra-
dation that could explain the effects that we observed.
These changes in liver lipid content are similar to those
reported in humans with AFL and, thus we propose, that
Clock-mutant mice could serve as a good model for study-
ing AFL formation.
Conclusion
We found that ethanol treatment produced a number of
changes in the liver of Clock-mutant mice without impact-
ing the wild-type controls. First, we found that 8 weeks of
exposure to ethanol in the drinking water increased the
weight of the liver in Clock-mutant mice. Ethanol treat-
ment also increased triglyceride content of liver in Clock-
mutant and wild-type mice. This increase was larger in the
mutant mice. Finally, ethanol treatment altered the
expression of a number of genes related to lipid metabo-
lism in the Clock-mutant mice.
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